Extract from the Register of European Patents

EP About this file: EP0783696

EP0783696 - PLATELET BLOCKADE ASSAY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.10.1999
Database last updated on 28.03.2026
Most recent event   Tooltip19.06.2009Change - representativepublished on 22.07.2009  [2009/30]
Applicant(s)For all designated states
MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK
One Gustave Levy Place, P.O. Box 1099
New York, NY 10029-6574 / US
[1997/29]
Inventor(s)01 / COLLER, Barry, S.
Apartment 6A, 1160 Park Avenue
New York, NY 10128 / US
[1997/29]
Representative(s)Barz, Peter
Meissner Bolte & Partner GbR
Postfach 86 06 24
81633 München / DE
[N/P]
Former [2009/30]Barz, Peter
Patentanwalt Kaiserplatz 2
80803 München / DE
Former [1997/29]Barz, Peter, Dr.
Patentanwalt Kaiserplatz 2
80803 München / DE
Application number, filing date95935026.520.09.1995
[1997/29]
WO1995US11986
Priority number, dateUS1994031502629.09.1994         Original published format: US 315026
[1997/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9610749
Date:11.04.1996
Language:EN
[1996/16]
Type: A1 Application with search report 
No.:EP0783696
Date:16.07.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 11.04.1996 takes the place of the publication of the European patent application.
[1997/29]
Type: B1 Patent specification 
No.:EP0783696
Date:02.12.1998
Language:EN
[1998/49]
Search report(s)International search report - published on:EP11.04.1996
ClassificationIPC:G01N33/86
[1997/29]
CPC:
G01N33/86 (EP,US); G01N33/5091 (EP,US); Y10S435/975 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/29]
TitleGerman:BLUTPLÄTTCHEN BLOCKADE TEST[1998/49]
English:PLATELET BLOCKADE ASSAY[1997/29]
French:TEST D'EVALUATION DU BLOCAGE DES PLAQUETTES SANGUINES[1997/29]
Former [1997/29]BLUTPLÜTTCHEN BLOCKADE TEST
Entry into regional phase27.03.1997National basic fee paid 
27.03.1997Designation fee(s) paid 
27.03.1997Examination fee paid 
Examination procedure26.04.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
27.03.1997Examination requested  [1997/29]
04.11.1997Despatch of a communication from the examining division (Time limit: M04)
27.02.1998Reply to a communication from the examining division
29.04.1998Despatch of communication of intention to grant (Approval: Yes)
04.06.1998Communication of intention to grant the patent
06.08.1998Fee for grant paid
06.08.1998Fee for publishing/printing paid
Opposition(s)03.09.1999No opposition filed within time limit [1999/47]
Fees paidRenewal fee
08.09.1997Renewal fee patent year 03
04.09.1998Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]   E.F. PLOW ET AL.: "The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 82, WASHINGTON US, pages 8057 - 8061 [A] 8,9,12,23,24,27,42,43,47 * the whole document *
 [A]   SHEU, JOEN RONG ET AL: "Triflavin, an Arg-Gly-Asp-containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line", THROMB. RES. (1992), 66(6), 679-91 CODEN: THBRAA;ISSN: 0049-3848 [A] 8,9 * the whole document *
 [A]   S.A. SANTORO ET AL.: "Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from paltelet adhesive proteins", CELL, vol. 48, 13 March 1987 (1987-03-13), NA US, pages 867 - 873 [A] 8,9,12,23,24,27,42,43,47 * the whole document *
 [PA]   J. CARR ET AL.: "Glycoprotein IIb/IIIa blockade inhibits platelet.mediated force development and reduces gel elastic modulus", THROMBOSIS AND HAEMOSTASIS, vol. 73, no. 3, CHAPEL HILL, pages 499 - 505 [PA] 1-47 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.